ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
B013K In force
MEDICAŢIA ADJUVANTĂ TERAPIEI ANTIVIRALE ÎN HEPATITE CRONICE (FILGRASTIM)
Sublist / disease code
C1-G4, G7
reimbursement list
Continuation by the family doctor
*
Listed since
November 2025
position 3 in the order
Last amended
November 2025
1 versions since November 2025
1
Medicines
From the protocol title (medicines of the protocol) and other substances mentioned in the text (combinations, previous treatments, interactions)
Medicines of the protocol
Mentioned in the text
2
Brand products authorised in Romania
From the ANMDM register, for the medicines of the protocol
FILGRASTIMUM 8 products
List of products (8 presentations)
| INN | Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|---|
| FILGRASTIMUM | ACCOFIL 12 MU/0,2 ml | SOL. INJ. SAU PERF. IN SERINGA PREUMPLUTA | 12 MU/0,2 ml | ACCORD HEALTHCARE S.L.U. - SPANIA | L03AA02 | PR |
| FILGRASTIMUM | ACCOFIL 30 MU/0,5 ml | SOL. INJ. SAU PERF. IN SERINGA PREUMPLUTA | 30MU/0,5 ml | ACCORD HEALTHCARE S.L.U. - SPANIA | L03AA02 | PR |
| FILGRASTIMUM | ACCOFIL 48 MU/0,5 ml | SOL. INJ. SAU PERF. IN SERINGA PREUMPLUTA | 48MU/0,5 ml | ACCORD HEALTHCARE S.L.U. - SPANIA | L03AA02 | PR |
| FILGRASTIMUM | ACCOFIL 70 MU/0,73 ml | SOL. INJ. SAU PERF. IN SERINGA PREUMPLUTA | 70 MU/0,73 ml | ACCORD HEALTHCARE S.L.U. - SPANIA | L03AA02 | PR |
| FILGRASTIMUM | NIVESTIM 30 MU/0,5 ml | SOL. INJ./PERF. | 300µg/0,5ml | PFIZER EUROPE MA EEIG - BELGIA | L03AA02 | PR |
| FILGRASTIMUM | NIVESTIM 48 MU/0,5 ml | SOL. INJ./PERF. | 480µg/0,5ml | PFIZER EUROPE MA EEIG - BELGIA | L03AA02 | PR |
| FILGRASTIMUM | ZARZIO 30MU/0,5ml | SOL. INJ. /PERF. IN SERINGA PREUMPLUTA | 60MU/ml | SANDOZ GMBH - AUSTRIA | L03AA02 | P-RF/R |
| FILGRASTIMUM | ZARZIO 48MU/0,5ml | SOL. INJ. /PERF. IN SERINGA PREUMPLUTA | 96MU/ml | SANDOZ GMBH - AUSTRIA | L03AA02 | P-RF/R |
3
History
The versions of the protocol from the Ministry of Health / CNAS orders, with medicines added / removed and the changed text
November 2025
baseline listlista protocoalelor terapeutice NOIEMBRIE 2025 A-C
Protocol text (version of November 2025, in Romanian)
Protocol terapeutic corespunzător poziţiei nr. 3, cod (B013K): MEDICAŢIA ADJUVANTĂ
TERAPIEI ANTIVIRALE ÎN HEPATITE CRONICE
DCI: FILGRASTIM
Indicaţii
Utilizarea filgrastim pentru susţinerea terapiei antivirale la doze optime.
Tratament
Doze
- Se începe administrarea de filgrastim 5 micrograme/kgc/zi timp de 3 zile consecutiv dacă
granulocitele scad la 1.000 mm3.
- Gr: 750 - 1.000 mm3:
- filgrastim 5 micrograme/kgc/zi timp de 3 zile;
- doză întreagă de interferon.
- Gr: 500 - 750 mm3:
- filgrastim 5 micrograme/kgc/zi timp de 3 zile;
- reducerea dozei de interferon conform protocolului.
- Gr: < 500 mm3:
- filgrastim 5 micrograme/kgc/zi timp de 3 zile;
- întreruperea interferonului conform protocolului.
Monitorizare
Monitorizarea se realizează prin identificarea săptămânală a numărului de granulocite.